The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1-cyclopentyl-1H-benzo[d][1,2,3]triazol-5-yl)-5-(4-fluorophenyl)-1,2,4-oxadiazole ID: ALA3735905
PubChem CID: 22583268
Max Phase: Preclinical
Molecular Formula: C19H16FN5O
Molecular Weight: 349.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccc(-c2nc(-c3ccc4c(c3)nnn4C3CCCC3)no2)cc1
Standard InChI: InChI=1S/C19H16FN5O/c20-14-8-5-12(6-9-14)19-21-18(23-26-19)13-7-10-17-16(11-13)22-24-25(17)15-3-1-2-4-15/h5-11,15H,1-4H2
Standard InChI Key: LRRVNQIIXFMMNH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1749 2.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 -1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7580 -2.9756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2259 -3.2843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9730 -1.9836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9669 -0.8711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.8393 -4.6540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0560 -5.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7704 -7.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2699 -7.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.0549 -6.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.3406 -4.6901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8414 -8.3424 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3751 3.8801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3406 5.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7308 4.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6243 2.9682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 1 0
3 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 11 2 0
13 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
10 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.37Molecular Weight (Monoisotopic): 349.1339AlogP: 4.40#Rotatable Bonds: 3Polar Surface Area: 69.63Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.15CX LogP: 4.95CX LogD: 4.95Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.55Np Likeness Score: -2.15
References 1. Ellard JM, Madin A, Philps O, Hopkin M, Henderson S, Birch L, O'Connor D, Arai T, Takase K, Morgan L, Reynolds D, Talma S, Howley E, Powney B, Payne AH, Hall A, Gartlon JE, Dawson LA, Castro L, Atkinson PJ.. (2015) Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition., 25 (24): [PMID:26531152 ] [10.1016/j.bmcl.2015.10.050 ]